Duncan Lisa, Jacob Sanjivini, Hubbard Elizabeth
Department of Pathology, University of Tennessee Medical Center, Knoxville, Tennessee 37920, USA.
Cancer. 2008 Feb 25;114(1):34-48. doi: 10.1002/cncr.23255.
P16(INK4a) (p16) has emerged as a biomarker for the detection of high-risk human papillomavirus (HR-HPV) in Papanicolaou (Pap) smears. Many studies have confirmed a strong correlation between p16 immunohistochemical positivity and high-grade squamous intraepithelial lesions (HSIL) of the cervix. Because p16 is predictive of HR-HPV and HSIL, it seems plausible that p16 could be used as a diagnostic tool to triage atypical squamous cells of undetermined significance (ASCUS) Pap smears. In this way, Pap smears with no p16 staining could be recategorized as negative for intraepithelial lesion or malignancy (NILM) before final case disposition, thus preventing unnecessary and costly follow-up.
p16 immunostains were performed on 178 ThinPrep (Cytyc, Marlborough, Mass) Pap smears signed out as ASCUS among 5 cytopathologists. p16 stains were independently scored between 0 (no staining) and 4 (staining in cells with nuclear aberration) by either 2 or 3 pathologists. The p16 score was compared with both Hybrid Capture 2 (hc(2)) (Digene, Gaithersburg, Md) and follow-up (Pap smear and tissue) results.
The sensitivity and specificity of p16 immunohistochemistry compared with both hc(2) and follow-up were not statistically significant, with both data subsets having P-values greater than .05.
Statistical significance was not demonstrated in any of the data subsets, indicating that the p16 score alone cannot be used to recategorize Pap smears from ASCUS to NILM as a means to prevent unnecessary and expensive follow-up. Although not meeting criteria for statistical significance, the sensitivity and positive predictive value of p16 scores versus tissue follow-up only were more statistically favorable, suggesting that p16 has better correlation with tissue follow-up than results of hc(2). In addition, p16 staining was identified consistently in atrophic Pap smears, including 23 of 25 additional NILM atrophic smears stained, indicating that p16 cannot be used as a marker to triage atypical atrophic smears.
P16(INK4a)(p16)已成为在巴氏涂片检查中检测高危人乳头瘤病毒(HR-HPV)的生物标志物。许多研究已证实p16免疫组化阳性与宫颈高级别鳞状上皮内病变(HSIL)之间存在密切关联。由于p16可预测HR-HPV和HSIL,因此p16可作为一种诊断工具,对意义不明确的非典型鳞状细胞(ASCUS)巴氏涂片进行分流,这似乎是合理的。通过这种方式,在最终病例处置前,无p16染色的巴氏涂片可重新分类为上皮内病变或恶性肿瘤阴性(NILM),从而避免不必要且昂贵的后续检查。
对5名细胞病理学家诊断为ASCUS的178份ThinPrep(Cytyc公司,马萨诸塞州马尔伯勒)巴氏涂片进行p16免疫染色。由2名或3名病理学家将p16染色独立评分,范围为0(无染色)至4(核异常细胞中的染色)。将p16评分与杂交捕获2(hc(2))(Digene公司,马里兰州盖瑟斯堡)及后续检查结果(巴氏涂片和组织)进行比较。
与hc(2)和后续检查结果相比,p16免疫组化的敏感性和特异性无统计学意义,两个数据子集的P值均大于0.05。
在任何数据子集中均未显示出统计学意义,这表明仅p16评分不能用于将巴氏涂片从ASCUS重新分类为NILM以避免不必要且昂贵的后续检查。尽管未达到统计学意义标准,但p16评分与仅组织后续检查结果相比,其敏感性和阳性预测值在统计学上更具优势,这表明p16与组织后续检查的相关性优于hc(2)的结果。此外,在萎缩性巴氏涂片中始终能检测到p16染色,包括25份额外的NILM萎缩性涂片中的23份,这表明p16不能用作分流非典型萎缩性涂片的标志物。